All Roll Calls
Yes: 118 • No: 0
Sponsored By: Barbara Kirkmeyer (Republican), Lindsay Gilchrist (Democratic), Lindsey Daugherty (Democratic), Rose Pugliese
Signed by Governor
Personalized for You
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
4 provisions identified: 2 benefits, 1 costs, 1 mixed.
If a patient dies while receiving an individualized experimental drug, biological product, or device, heirs do not owe related unpaid debt. This includes treatment costs caused by a lack of insurance coverage. The law sets no dollar limit on this protection.
Colorado allows patients with life-threatening or severely debilitating illnesses to request experimental treatments made specifically for their genetic profile. A doctor must confirm eligibility, recommend treatment, and document that all FDA-approved options were considered. Written informed consent is required, with parent or guardian consent for minors under 18. Consent must identify the treatment, explain approved alternatives, and state that approved treatments likely will not prolong life. It must explain best and worst outcomes, new side effects, possible hospice consequences, and possible denial of in-home care. Manufacturers must operate within eligible facilities covered by federal human-subject protections and follow federal law. They can refuse requests, provide treatment free, or charge manufacturing and related costs. The law adds no insurance coverage requirement and preserves existing coverage obligations for clinical trials. Consent must explain payer obligations and the patient's responsibility for expenses unless a contract says otherwise. State officials cannot block or attempt to block eligible patients' access; providers can still give advice that meets medical standards. The detailed treatment program took effect immediately.
Colorado licensing boards cannot penalize providers solely for recommending access to or treatment with an individualized experimental product. The recommendation must concern an eligible patient and meet medical standards of care. The law also bars revoking or conditioning Medicare certification solely for such a recommendation. These protections do not guarantee that a patient receives treatment.
The law creates no new private right to sue for harm caused by an individualized experimental treatment. This limit applies when manufacturers or others involved made a good-faith effort to follow the law and used reasonable care. It does not bar every treatment-related claim.
Barbara Kirkmeyer
Republican • Senate
Lindsay Gilchrist
Democratic • House
Lindsey Daugherty
Democratic • Senate
Rose Pugliese
Affiliation unavailable
Andrew Boesenecker
Democratic • House
Brandi Bradley
Republican • House
Bob Marshall
Democratic • House
Brianna Titone
Democratic • House
Carlos Barron
Republican • House
Chad Clifford
Democratic • House
Cecelia Espenoza
Democratic • House
Dusty Johnson
Republican • House
Eliza Hamrick
Democratic • House
Jennifer Bacon
Democratic • House
Jarvis Caldwell
Republican • House
Jamie Jackson
Democratic • House
Julie McCluskie
Democratic • House
Karen McCormick
Democratic • House
Katie Stewart
Democratic • House
Lisa Feret
Democratic • House
Lori Garcia Sander
Republican • House
Lorena Garcia
Democratic • House
Monica Duran
Democratic • House
Meg Froelich
Democratic • House
Mandy Lindsay
Democratic • House
Matthew Martinez
Democratic • House
Manny Rutinel
Democratic • House
Regina English
Democratic • House
Ryan Gonzalez
Republican • House
Rebecca Keltie
Republican • House
Rick Taggart
Republican • House
Ron Weinberg
Republican • House
Rep. S. Bird
Affiliation unavailable
Sean Camacho
Democratic • House
Sheila Lieder
Democratic • House
Tammy Story
Democratic • House
Ty Winter
Republican • House
Byron Pelton
Republican • Senate
Cathy Kipp
Democratic • Senate
Cleave Simpson
Republican • Senate
Dafna Michaelson Jenet
Democratic • Senate
Dylan Roberts
Democratic • Senate
Iman Jodeh
Democratic • Senate
Judy Amabile
Democratic • Senate
Katie Wallace
Democratic • Senate
Lisa Cutter
Democratic • Senate
Lisa Frizell
Republican • Senate
Marc Catlin
Republican • Senate
Nick Hinrichsen
Democratic • Senate
Scott Bright
Republican • Senate
All Roll Calls
Yes: 118 • No: 0
Senate vote • 4/14/2025
Third reading: Bill
Yes: 33 • No: 0
Senate vote • 4/10/2025
Refer House Bill 25-1270 to the Committee of the Whole and with a recommendation that it be placed on the consent calendar.
Yes: 9 • No: 0
House vote • 3/14/2025
Third reading: Bill
Yes: 64 • No: 0
House vote • 3/5/2025
Refer House Bill 25-1270 to the Committee of the Whole.
Yes: 12 • No: 0
Governor Signed
Sent to the Governor
Signed by the Speaker of the House
Signed by the President of the Senate
Senate Third Reading Passed - No Amendments
Senate Second Reading Special Order - Passed - No Amendments
Senate Committee on Health & Human Services Refer Unamended - Consent Calendar to Senate Committee of the Whole
Introduced In Senate - Assigned to Health & Human Services
House Third Reading Passed - No Amendments
House Second Reading Special Order - Passed - No Amendments
House Second Reading Laid Over Daily - No Amendments
House Committee on Health & Human Services Refer Unamended to House Committee of the Whole
Introduced In House - Assigned to Health & Human Services
Engrossed
Final Act
Introduced
Reengrossed
Rerevised
Revised
Signed Act